expression rrid addgene 232062 egfp rab8a rrid addgene 49543 gfp rab7 rrid addgene 12605 pqe30 darpin e11 n (Addgene inc)
92
Structured Review
Addgene inc
expression rrid addgene 232062 egfp rab8a rrid addgene 49543 gfp rab7 rrid addgene 12605 pqe30 darpin e11 n
Expression Rrid Addgene 232062 Egfp Rab8a Rrid Addgene 49543 Gfp Rab7 Rrid Addgene 12605 Pqe30 Darpin E11 N, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp+rab8a/EGFP-Rab8+(Plasmid+%2349543)/pmc12136037__sciadv%2Eadt2050_sm-44-84-86
Average 92 stars, based on 7 article reviews
Expression Rrid Addgene 232062 Egfp Rab8a Rrid Addgene 49543 Gfp Rab7 Rrid Addgene 12605 Pqe30 Darpin E11 N, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp+rab8a/EGFP-Rab8+(Plasmid+%2349543)/pmc12136037__sciadv%2Eadt2050_sm-44-84-86
Average 92 stars, based on 7 article reviews
expression rrid addgene 232062 egfp rab8a rrid addgene 49543 gfp rab7 rrid addgene 12605 pqe30 darpin e11 n - by Bioz Stars,
2026-11
92/100 stars
Images
Related Articles
Transfection:Article Title: Type-II kinase inhibitors that target Parkinson’s Disease-associated LRRK2 Article Snippet: To determine the IC50, a non-linear regression with variable slope was fitted to the datapoints with GraphPad Prism. (For step-by-step protocol see: dx.doi.org/10.17504/protocols.io.6qpvr385ovmk/v2 ). .. 293T cells (American Type Culture Collection, ATCC cat. no. CRL-3216, RRID: CVCL_0063) were transfected with 1000 ng of wild-type full-length LRRK2 (pcDNA5-LRRK2) and 500 ng Article Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2 Article Snippet: To determine the IC 50 , a nonlinear regression with variable slope was fitted to the datapoints with GraphPad Prism ( www.graphpad.com/ , RRID:SCR_002798). (For step-by-step protocol, see dx.doi.org/10.17504/protocols.io.6qpvr385ovmk/v2 .) .. For Western blot analysis of LRRK2 kinase activity in cells, 293T cells (ATCC, CRL-3216; RRID: CVCL_0063) were transfected with 1000 ng of wild-type full-length LRRK2 (pcDNA5-LRRK2, RRID: Addgene_229019) and 500 ng of Article Title: A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2 Article Snippet: .. 293T cells (American Type Culture Collection, ATCC cat. no. CRL-3216, RRID: CVCL_0063) were transfected with 1000 ng of WT, full-length, untagged LRRK2 (pCDNA5-LRRK2) and 500 ng Article Title: A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2. Article Snippet: Please cite this article as: Dederer V, Sanz Murillo M, Karasmanis EP, Hatch KS, Chatterjee D, Preuss F, Abdul Azeez KR, Vu Nguyen L, Galicia C, Dreier B, Plückthun A, Versees W, Mathea S, Leschziner AE, Reck-Peterson SL, Knapp S, A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2, Journal of Biological Chemistry (2024), doi: https://doi.org/10.1016/ j.jbc.2024.107469. Western Blot:Article Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2 Article Snippet: To determine the IC 50 , a nonlinear regression with variable slope was fitted to the datapoints with GraphPad Prism ( www.graphpad.com/ , RRID:SCR_002798). (For step-by-step protocol, see dx.doi.org/10.17504/protocols.io.6qpvr385ovmk/v2 .) .. For Western blot analysis of LRRK2 kinase activity in cells, 293T cells (ATCC, CRL-3216; RRID: CVCL_0063) were transfected with 1000 ng of wild-type full-length LRRK2 (pcDNA5-LRRK2, RRID: Addgene_229019) and 500 ng of Analysis:Article Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2 Article Snippet: To determine the IC 50 , a nonlinear regression with variable slope was fitted to the datapoints with GraphPad Prism ( www.graphpad.com/ , RRID:SCR_002798). (For step-by-step protocol, see dx.doi.org/10.17504/protocols.io.6qpvr385ovmk/v2 .) .. For Western blot analysis of LRRK2 kinase activity in cells, 293T cells (ATCC, CRL-3216; RRID: CVCL_0063) were transfected with 1000 ng of wild-type full-length LRRK2 (pcDNA5-LRRK2, RRID: Addgene_229019) and 500 ng of Activity Assay:Article Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2 Article Snippet: To determine the IC 50 , a nonlinear regression with variable slope was fitted to the datapoints with GraphPad Prism ( www.graphpad.com/ , RRID:SCR_002798). (For step-by-step protocol, see dx.doi.org/10.17504/protocols.io.6qpvr385ovmk/v2 .) .. For Western blot analysis of LRRK2 kinase activity in cells, 293T cells (ATCC, CRL-3216; RRID: CVCL_0063) were transfected with 1000 ng of wild-type full-length LRRK2 (pcDNA5-LRRK2, RRID: Addgene_229019) and 500 ng of Expressing:Article Title: Insufficiency of ciliary cholesterol in hereditary Zellweger syndrome Article Snippet: .. ECFP‐SKL (#54548), Article Title: Endocytosis is regulated through the pH-dependent phosphorylation of Rab GTPases by Parkinson’s kinase LRRK2 Article Snippet: .. Reagents Mammalian expression vectors were obtained from the following sources: CFP-Rab5A 82; GFP-Rab5A 83; RFP-Rab5A 84; CFP-Rab5A(Q79L) 82; GFP-Rab5A(Q79L) (35140, Addgene); mCherry-Rab5A(Q79L) (35138, Addgene); CFP-Rab5A(S34N) 82; RFP-Rab7A 85; RFP-Rab7A(Q67L) 85, RFPRab7A(T22N) 85; GFP-Rab7A 86; GFP-Rab7A(Q67L) 86; GFP-Rab10A (49472, Addgene); Article Title: Endocytosis is regulated through the pH-dependent phosphorylation of Rab GTPases by Parkinson’s kinase LRRK2 Article Snippet: .. Mammalian expression vectors were obtained from the following sources: CFP-Rab5A ; GFP-Rab5A ; RFP-Rab5A ; CFP-Rab5A(Q79L) ; GFP-Rab5A(Q79L) (35140, Addgene); mCherry-Rab5A(Q79L) (35138, Addgene); CFP-Rab5A(S34N) ; RFP-Rab7A ; RFP-Rab7A(Q67L) , RFP-Rab7A(T22N) ; GFP-Rab7A ; GFP-Rab7A(Q67L) ; GFP-Rab10A (49472, Addgene); other:Article Title: Podosome assembly is controlled by the GTPase ARF1 and its nucleotide exchange factor ARNO Article Snippet: The following plasmids described were purchased from Kinase Assay:Article Title: A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2. Article Snippet: Please cite this article as: Dederer V, Sanz Murillo M, Karasmanis EP, Hatch KS, Chatterjee D, Preuss F, Abdul Azeez KR, Vu Nguyen L, Galicia C, Dreier B, Plückthun A, Versees W, Mathea S, Leschziner AE, Reck-Peterson SL, Knapp S, A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2, Journal of Biological Chemistry (2024), doi: https://doi.org/10.1016/ j.jbc.2024.107469. |
